Antiemetic effect of Metoclopromide is mainly due to its action as
**Core Concept**
Metoclopramide is a prokinetic agent that exerts its antiemetic effects by modulating the activity of neurotransmitters in the central nervous system and the gastrointestinal tract. The primary mechanism of action involves the blockade of dopamine receptors, specifically D2 receptors, in the chemoreceptor trigger zone (CTZ) of the brain.
**Why the Correct Answer is Right**
The blockade of D2 receptors in the CTZ reduces the vomiting reflex, thereby exerting its antiemetic effects. Metoclopramide also has a role in enhancing the release of acetylcholine from the vagus nerve terminals, which increases gastrointestinal motility and prevents gastric stasis. This action further contributes to its antiemetic and prokinetic effects.
**Why Each Wrong Option is Incorrect**
**Option A:** Dopamine release is not the primary mechanism of action for metoclopramide's antiemetic effects. In fact, metoclopramide blocks dopamine release in the CTZ.
**Option B:** The muscarinic receptor blockade is not the main mechanism of action for metoclopramide's antiemetic effects. Metoclopramide primarily acts on dopamine receptors in the CTZ.
**Option C:** Serotonin receptor blockade is not the primary mechanism of action for metoclopramide's antiemetic effects. Although metoclopramide may have some effect on serotonin receptors, its antiemetic effects are mainly due to dopamine receptor blockade.
**Clinical Pearl / High-Yield Fact**
Metoclopramide is a useful antiemetic agent in patients undergoing chemotherapy, radiation therapy, and in those with gastroparesis. However, its use is limited by its potential to cause extrapyramidal side effects, such as dystonia and parkinsonism, particularly in the elderly and in patients with a history of neuroleptic malignant syndrome.
**Correct Answer: C. Blockade of dopamine receptors in the chemoreceptor trigger zone.**